- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
CannaRoyalty Investee Posts Results from First Arizona Dispensary
CannaRoyalty shared the operational results from the opening of the inaugural dispensary in Arizona by its partner Alternative Medical Enterprises.
CannaRoyalty (CSE:CRZ; OTCQX:CNNRF) shared the operational results from the opening of the inaugural dispensary in Arizona by its partner Alternative Medical Enterprises.
As quoted in the press release:
The Dispensary, the first of several planned for the state, brings the entire award-winning line of MüV cannabis infused products together in a single location and offers order-ahead pickup and delivery. AltMed also continues to offer its popular MüV products wholesale to many other dispensaries across the state.
“The successful grand opening of the first MüV by AltMed dispensary in Arizona is an important milestone for AltMed and for CannaRoyalty shareholders,” said Marc Lustig, CEO of CannaRoyalty.
AltMed CEO Michael Smullen added, “We had over 1,000 patients visit our Phoenix dispensary during the grand opening week and we generated sales well ahead of our expectations.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.